Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiliang Xie

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Pharmaceutics|June 16, 2022
Engineering Bio-MOF/polydopamine as a biocompatible targeted theranostic system for synergistic multi-drug chemo-photothermal therapyShasha Yang, Zhihuan Zhao, Yiliang Xie, et al.
Chemosphere|December 10, 2020
Intensity analysis of chromium cycling in south Jiangsu region of ChinaTong Zhang, Ganpei Tian, Xiuren Hu, et al.
IEEE Transactions on Cybernetics|June 11, 2019
Task-Oriented Feature-Fused Network With Multivariate Dataset for Joint Face AnalysisXuxin Lin, Jun Wan, Yiliang Xie, et al.
Bioconjugate Chemistry|October 15, 2025
Double-Responsive Metallic Magnetic Nanoparticles Based on Tumor Microenvironment "Leverage" Rebalancing for Triple Collaborative Cancer TherapyYimei Zhang, Liqun Wei, Xiaole Yin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Pharmaceutics|June 16, 2022
Engineering Bio-MOF/polydopamine as a biocompatible targeted theranostic system for synergistic multi-drug chemo-photothermal therapyShasha Yang, Zhihuan Zhao, Yiliang Xie, et al.
Chemosphere|December 10, 2020
Intensity analysis of chromium cycling in south Jiangsu region of ChinaTong Zhang, Ganpei Tian, Xiuren Hu, et al.
IEEE Transactions on Cybernetics|June 11, 2019
Task-Oriented Feature-Fused Network With Multivariate Dataset for Joint Face AnalysisXuxin Lin, Jun Wan, Yiliang Xie, et al.
Bioconjugate Chemistry|October 15, 2025
Double-Responsive Metallic Magnetic Nanoparticles Based on Tumor Microenvironment "Leverage" Rebalancing for Triple Collaborative Cancer TherapyYimei Zhang, Liqun Wei, Xiaole Yin, et al.
Pageof 1